Food and Drug Administration

FILE - This Aug. 2, 2018 file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The Food and Drug Administration has issued a negative review of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease. The review comes ahead of a meeting this week for outside experts to vote on the drug for ALS. The drug has been the focal point of a lobbying campaign by patients, their families and lawmakers. FDA reviewers said Monday, March 28, 2022 the single study from Amylyx Pharmaceuticals was “not persuasive” due to missing data, errors in enrolling patients and other problems. (AP Photo/Jacquelyn Martin, File)

Deadline approaches to pass bill affecting employment for 3,500 FDA workers

Thousands of employees at the Food and Drug Administration would face potential furlough if user fee program legislation isn’t passed by Sept. 30.

Read more
Joshua Roberts

This FDA lawyer was instrumental in limits on cigarette marketing

Read more
Joshua Roberts

This FDA scientist’s work helps public health officials find sources of tainted food faster

Read more
A due to limited supplies sign is shown on the baby formula shelf at a grocery store Tuesday, May 10, 2022, in Salt Lake City. Parents across much of the U.S. are scrambling to find baby formula after a combination of supply disruptions and safety recalls have swept many of the leading brands off store shelves. (AP Photo/Rick Bowmer)

Federal agencies’ roles in helping to solve the baby formula shortage

Read more
Amelia Brust/Federal News Network

First HHS chief AI officer sees promise in 100 AI use cases, but challenges moving them forward

Read more
Smith Pachter McWhorter PLC

Agency cancels third-party software license but original vendor still claims infringement

Read more

CIOs at HHS, TSA, CTO at Justice leaving federal service

Long-time data guru Tom Beach joins the FDA while GSA shuffles some seats after Carlton Shufflebarger retires after 37 years in government.

Read more

Through new Office of Digital Transformation, FDA putting business ahead of IT

Vid Desai, FDA’s chief information officer, said the new Office of Digital Transformation will improve their ability to govern more effectively, reduce…

Read more
Robert Califf

Biden picks ex-FDA chief Robert Califf to again lead agency

President Joe Biden is nominating former Food and Drug Administration Commissioner Dr. Robert Califf to again lead the powerful regulatory agency

Read more